期刊文献+

组蛋白去乙酰化酶抑制剂对乳腺癌细胞株MCF-7增殖周期的影响 被引量:10

The effect of histone deacetylase inhibitors on cell cycle of breast cancer cell line MCF-7
原文传递
导出
摘要 目的研究组蛋白去乙酰化酶抑制荆对乳腺癌细胞株增殖周期的影响。方法培养乳腺癌细胞株MCF-7,用TSA、SAHA、CS055、MS-2754种不同类型的组蛋白去乙酰化酶抑制剂分别作用于细胞,于24、48、72、96h用MTr比色法观察细胞生长情况,初筛出高效的抑制剂。用所选出的抑制剂的不同浓度处理细胞,流式细胞术检测S期细胞的比例和周期素CyclinD1、CyclinA2,并进行统计分析。结果在TSA、SAHA、CS055和MS-2754种不同类型的组蛋白去乙酰化酶抑制剂中,SAHA显示出较强的抑制能力(P〈0.05);在一定时间和浓度范围内,其抑制能力有明显的时效关系;在抑制剂作用下,S期细胞比例和周期素CyelinA2表达下降,CyelinD1表达上升(P均〈0.05)。结论组蛋白去乙酰化酶抑制剂SAHA是乳腺癌细胞增殖的高效抑制剂,其抑制作用有一定的时效关系;周期素CyclinD1、CyelinA2参与了抑制剂对细胞增殖周期的调控。 Objective To study the effect of histone deacetylase inhibitors on cell cycle of breast cancer cell line MCF-7. Methods The breast cancer cell line MCF-7 was treated by histone deacetylase inhibitors (TSA, SAHA,CS055,MS-275) respectively and observed by MT'F assay after 24 hours, 48 hours, 72 hours, 96 hours. The chosen inhibitor was used to treat MCF-7 cell in different concentration. The flow cytometry was used to detect the S- phase cell and Cyclin A2, Cyclin D1. SPSS 10.0 was used to analyze the data. Results Within the four inhibitors, SAHA showed the must powerful effect of depression of cell growth and time-effect relation. The percentage of S-phase ceils and level of Cyclin A2 decreased, the level of Cyclin D1 increased. Conclusions SAHA is the most powerful histone deacetylase inhibitors for breast cancer cell MCF-7 , the effect of depression of cell growth shows time-effect relation. Cyclin A2 and Cyelin D1 were involed in this regulation of cell cycle.
出处 《中国综合临床》 2009年第12期1238-1240,共3页 Clinical Medicine of China
基金 云南省科技计划项目(2007C0026R)
关键词 乳腺癌 组蛋白去乙酰化酶抑制剂 细胞周期 Breast neoplasm Histone deacetylase inhibitor Cell cycle
  • 相关文献

参考文献11

二级参考文献113

  • 1谢爱华,廖晨钟,李伯玉,山松,邓沱,李志斌,宁志强,胡伟明,石乐明,周家驹,鲁先平.以组蛋白去乙酰化酶为靶标的抗癌药物研发进展[J].中国新药杂志,2005,14(1):10-14. 被引量:8
  • 2陈小贺,蔡建辉.细胞周期素D1、p16基因与肿瘤相关性的研究[J].实用肿瘤学杂志,2006,20(1):76-78. 被引量:5
  • 3范钰,郑树,赵刚.青蒿琥酯对乳腺癌MCF-7细胞抗失巢凋亡的影响[J].中国病理生理杂志,2006,22(4):748-751. 被引量:25
  • 4Friedrichs K, Gluba S, Eidtmann H, et al. Overexpression of p53 and prognosis in breast cancer[J]. Cancer, 1993, 72 (12): 3641-3647.
  • 5Efferth T, Dunstan H, Sauerbrey A, et al. The antimalarial artesunate is also active against cance [J]. Int J Oncol, 2001, 18(4):767-773.
  • 6Reed JC. Apoptosis-targeted therapies for cancer[J]. Cancer Cell, 2003, 3(1): 17-22.
  • 7Efferth T, Benakis A, Romero MR, et al. Enhaneement of eytotoxieity of artemisinins toward cancer cells by ferrous iron[J]. Free Radic Biol Med, 2004, 37(7):998-1009.
  • 8Berger T, Dieckmann D, Efferth T, et al. Artesunate in the treatment of metastatic uveal melanoma-first experiences [J]. Oncol Rep, 2005, 14(6) : 1599-1603.
  • 9[1]Chambers AE, Banerjee S, Chaplin T, et al. Histone acetylation-mediated regulation of genes in leukaemic cells [J].Eur J Cancer, 2003, 39(8): 1165-1175.
  • 10[2]Jay L'Grisolano, Julie O'Neal, Jennifer Cain, et al. An activated receptor tyrosine kinase, TEL/PDGFβR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice[J]. Medical Sciences, 2003,100(16):9506-9511.

共引文献49

同被引文献101

  • 1刘艾林,龙娟,王楠,杜冠华.抗肿瘤药物新靶点:组蛋白去乙酰酶的研究进展[J].药学学报,2005,40(7):585-590. 被引量:8
  • 2李作生,李保庆.p21和p27基因多态性与肿瘤的相关性[J].国际遗传学杂志,2006,29(4):317-320. 被引量:25
  • 3王颖,王生余,侯春梅,徐元基,杜芝燕,于晓妉.组蛋白去乙酰化酶抑制剂SAHA阻断MAPK信号通路并诱导HL-60细胞凋亡[J].中国实验血液学杂志,2007,15(2):267-271. 被引量:3
  • 4Gregoire S,Xiao L,Nie J,et al.Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2[J].Mol Cell Biol,2007,27(4):1280-1295.
  • 5Gregoire S,Tremblay AM,Xiao L,et al.Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation[J].J Biol Chem,2006,281(7):4423-4433.
  • 6Jallal H,Valentino ML,Chen G.A Src/Abl kinase inhibitor,SKI-606,blocks breast cancer invasion,growth,and metastasis in vitro and in vivo[J].Cancer Res,2007,67(4):1580-1588.
  • 7Ju X,Katiyar S,Wang C,et al.Akt1 governs breast cancer progression in vivo[J].Proc Natl Acad Sci U S A,2007,104(18):7438-7443.
  • 8Somers-Edgar TJ,Scandlyn MJ,Stuart EC,et al.The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo[J].Int J Cancer,2008,122(9):1966-1971.
  • 9Nyati MK,Symon Z,Kievit E,et al.The potential of 5-fluorocytosine/ cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model[J].Gene Ther,2002,9(13):844-849.
  • 10Gahr S,Peter G,Wissniowski TT,et al.The histone-deacetylase inhibitor MS-275 and the CDK-inhibitor CYC-202 promote anti-tumor effects in hepatoma cell lines[J].Oncol Rep,2008,20(5):1249-1256.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部